Cargando…

Evaluation of the draft guidelines proposed by EMA and FDA for the clinical diagnosis of acute uncomplicated cystitis in women

PURPOSE: To reassess the diagnostic values of the “draft” guidelines for the clinical diagnosis of acute uncomplicated cystitis (AC), recently proposed by US Food and Drug Administration (FDA) and European Medicines Agency (EMA). METHODS: The data of 517 female respondents (patients with acute cysti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alidjanov, Jakhongir F., Naber, Kurt G., Pilatz, Adrian, Radzhabov, Abdukhamid, Zamuddinov, Musluhuddin, Magyar, András, Tenke, Peter, Wagenlehner, Florian M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Topic Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954149/ https://www.ncbi.nlm.nih.gov/pubmed/31004204 http://dx.doi.org/10.1007/s00345-019-02761-3

Ejemplares similares

Linguistic and Clinical Validation of the Tajik Acute Cystitis Symptom Score for Diagnosis and Patient-Reported Outcome in Acute Uncomplicated Cystitis
por: Radzhabov, Abdukhamid, et al.
Publicado: (2023)

Additional assessment of Acute Cystitis Symptom Score questionnaire for patient-reported outcome measure in female patients with acute uncomplicated cystitis: part II
por: Alidjanov, J. F., et al.
Publicado: (2019)

Validation of the American English Acute Cystitis Symptom Score
por: Alidjanov, Jakhongir F., et al.
Publicado: (2020)

The role of the Acute Cystitis Symptom Score questionnaire for research and antimicrobial stewardship. Validation of the Hungarian version
por: Magyar, András, et al.
Publicado: (2017)

Linguistic and clinical validation of the Turkish version of Acute Cystitis Symptom Score for the diagnosis and patient-reported outcome in acute uncomplicated cystitis
por: Arda, Ersan, et al.
Publicado: (2023)

Polish version of the Acute Cystitis Symptom Score for patients with acute uncomplicated cystitis
por: Naber, Kurt G., et al.
Publicado: (2023)

Reevaluation of the Acute Cystitis Symptom Score, a Self-Reporting Questionnaire. Part II. Patient-Reported Outcome Assessment
por: Alidjanov, Jakhongir F., et al.
Publicado: (2018)

Reevaluation of the Acute Cystitis Symptom Score, a Self-Reporting Questionnaire. Part I. Development, Diagnosis and Differential Diagnosis
por: Alidjanov, Jakhongir F., et al.
Publicado: (2018)

Clinical Validation of the Greek Version of the Acute Cystitis Symptom Score (ACSS)—Part II
por: Stamatiou, Konstantinos, et al.
Publicado: (2021)

Acute Cystitis Symptom Score questionnaire for measuring patient-reported outcomes in women with acute uncomplicated cystitis: Clinical validation as part of a phase III trial comparing antibiotic and nonantibiotic therapy
por: Alidjanov, Jakhongir F., et al.
Publicado: (2020)

Acute Cystitis Symptom Score (ACSS): Clinical Validation of the Italian Version
por: Di Vico, Tommaso, et al.
Publicado: (2020)

AB127. Translation, adaptation and validation of Acute Cystitis Symptom Score’s German version
por: Alidjanov, JF, et al.
Publicado: (2014)

Translation and validation of the Korean version of acute cystitis symptom score
por: Choi, Jin Bong, et al.
Publicado: (2022)

Linguistic and clinical validation of the acute cystitis symptom score in German-speaking Swiss women with acute cystitis
por: Alidjanov, Jakhongir F., et al.
Publicado: (2021)

Condition-specific surveillance in health care-associated urinary tract infections as a strategy to improve empirical antibiotic treatment: an epidemiological modelling study
por: Tandogdu, Zafer, et al.
Publicado: (2019)

Validation of the Spanish Acute Cystitis Symptoms Score (ACSS) in native Spanish‐speaking women of Europe and Latin America
por: Medina‐Polo, José, et al.
Publicado: (2022)

Diagnosis of acute cystitis in primary care: symptom-based versus urinalysis-based diagnosis
por: Lelie- van der Zande, Rian, et al.
Publicado: (2022)

The negative aftermath of prostate biopsy: prophylaxis, complications and antimicrobial stewardship: results of the global prevalence study of infections in urology 2010–2019
por: Alidjanov, Jakhongir F., et al.
Publicado: (2021)

Psychosocial burden of recurrent uncomplicated urinary tract infections
por: Naber, Kurt G., et al.
Publicado: (2022)

Changes in the management of urinary tract infections in women: impact of the new recommendations on antibiotic prescribing behavior in France, between 2014 and 2019
por: Piraux, Arthur, et al.
Publicado: (2021)

The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA
por: Gherghescu, Ioana, et al.
Publicado: (2020)

Bearberry in the treatment of acute uncomplicated cystitis (BRUMI): protocol of a multicentre, randomised double-blind clinical trial
por: Tóth, Barbara, et al.
Publicado: (2022)

Calculated parenteral initial treatment of bacterial infections: Infections of the kidneys and the genito-urinary tract
por: Fünfstück, Reinhard, et al.
Publicado: (2020)

Spectrum and antibiotic resistance of catheter-associated urinary tract infections
por: Köves, Béla, et al.
Publicado: (2017)

Lutathera(®): The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy
por: Hennrich, Ute, et al.
Publicado: (2019)

EMA-FDA Parallel Scientific Advice: Optimizing Development of Medicines in the Global Age
por: Thor, Shannon, et al.
Publicado: (2023)

Difference in symptom manifestation between postmenopausal and premenopausal women in acute uncomplicated cystitis: A multi-institutional pilot study
por: Wanifuchi, Atsushi, et al.
Publicado: (2023)

Phytotherapy (BNO 1045) of Acute Lower Uncomplicated Urinary Tract Infection in Women Normalizes Local Host Responses
por: Butler, Daniel S.C., et al.
Publicado: (2023)

Urinary Microbiome Characteristics in Female Patients with Acute Uncomplicated Cystitis and Recurrent Cystitis
por: Yoo, Jeong-Ju, et al.
Publicado: (2021)

Impact of Education on Fluoroquinolone Use in Uncomplicated Cystitis
por: Ferren, Ryan, et al.
Publicado: (2017)

2840. Prevalence of Acute Uncomplicated Cystitis in Japan
por: Franklin, Meg, et al.
Publicado: (2023)

Expanded Access as a source of real‐world data: An overview of FDA and EMA approvals
por: Polak, Tobias B., et al.
Publicado: (2020)

Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies
por: Constantinescu, Catalin, et al.
Publicado: (2020)

FDA and EMA Approvals of New Breast Cancer Drugs—A Comparative Regulatory Analysis
por: Leo, Chandra P., et al.
Publicado: (2020)

First COVID-19 Vaccines Receiving the US FDA and EMA Emergency Use Authorization
por: Fortner, Andra, et al.
Publicado: (2021)

South African experts comment on FDA approval of dabigatran inatrial fibrillation
por: E, Klug, et al.
Publicado: (2011)

Elements of Regulatory Dissonance: Examining FDA and EMA Product Labeling of New Vaccines (2006–2018)
por: Seo, Yurim, et al.
Publicado: (2020)

EMA and FDA psychiatric drug trial guidelines: assessment of guideline development and trial design recommendations
por: Boesen, Kim, et al.
Publicado: (2021)

Considering Global Development? Insights from Applications for FDA Breakthrough Therapy and EMA PRIME Designations
por: Hanaizi, Zahra, et al.
Publicado: (2022)

Necessity of strengthening the current clinical regulatory for companion diagnostics: An institutional comparison of the FDA, EMA, and MFDS
por: Kang, Su Lim, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7fsqhs6reqpqdsinuohscaf07a